(INNS)
VONSETAMIG(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS TNFRSF17 (TNF RECEPTOR SUPERFAMILY MEMBER 17, BCMA, TNFRSF13A, CD269) AND CD3E (CD3 EPSILON)], HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT; GAMMA4 HEAVY CHAIN ANTI-TNFRSF17 HOMO SAPIENS (1-451) [VH (HOMO SAPIENS IGHV3-7*01 (93.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.18] (26-33.51-58.97-114)) (1-125) -HOMO SAPIENS IGHG4*01, G4V5 H P10, NG4M(A) CH2 L92, IGHG4V7 CH2 DELE1.4, P1.3, V1.2, A1.1 (CH1 (126-223), HINGE 1-12 S10>P (233) (224-235), CH2 E1.4>DEL, F1.3>P (238), L1.2>V (239), G1.1>A (240), L92 (313) (236-344), CH3 (345-449), CHS (450-451)) (126-451)], (139-215')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') [V-KAPPA (HOMO SAPIENS IGKV1-39*01 (100%) -IGKJ5*01 (100%), CDR-IMGT [6.3.10] (27-32.50-52.89-98)) (1'- 108') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (154), V101 (192) (109'- 215')]; ... PROPOSED INN: LIST 128, RECOMMENDED INN: LIST 90(WHO)
VONSETAMIGUM(INN)